Hereditary haemorrhagic telangiectasia, inherited as an autosomal dominant trait, affects
approximately 1 in 5000 people. The abnormal vascular structures in HHT result from …

Introduction: Percutaneous closure of patent foramen ovale (PFO) in selected patients with
cryptogenic cerebrovascular ischemic events (CEs) decreases the risk of recurrent stroke; …

Pulmonary arteriovenous malformations (PAVMs) are structurally abnormal vascular
communications that provide a continuous right-to-left shunt between pulmonary arteries …

Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant multisystemic
vascular dysplasia, characterized by arteriovenous malformations (AVMs), mucocutaneous …

We present a novel integrative computerized solution to automatically identify and
differentiate pulmonary arteries and veins depicted on chest computed tomography (CT) …

Activin A receptor like type 1 (ALK1) is a transmembrane serine/threonine receptor kinase in
the transforming growth factor-beta receptor family that is expressed on endothelial cells …

Pulmonary arteriovenous malformation, a condition most commonly associated with
hereditary hemorrhagic telangiectasia, is an abnormal communication between the …

Hereditary hemorrhagic telangiectasia (HHT) is a dominantly inherited genetic vascular
disorder with an estimated prevalence of 1 in 6,000, characterized by recurrent epistaxis …

Background Pulmonary first pass filtration of particles marginally exceeding∼ 7 µm (the size
of a red blood cell) is used routinely in diagnostics, and allows cellular aggregates forming …

Hereditary haemorrhagic telangiectasia (HHT) causes chronic nasal and gastrointestinal
haemorrhage. Prothrombotic agents are commonly used for severe haemorrhage …